loadpatents
name:-0.045135021209717
name:-0.016952037811279
name:-0.0004730224609375
Friedlander; Martin Patent Filings

Friedlander; Martin

Patent Applications and Registrations

Patent applications and USPTO patent grants for Friedlander; Martin.The latest application filed is for "tryptophanyl-trna synthetase-derived polypeptides useful for the regulation of angiogenesis".

Company Profile
0.17.34
  • Friedlander; Martin - Del Mar CA US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Treatment of cone cell degeneration with transfected lineage negative hematopoietic stem cells
Grant 8,900,567 - Friedlander , et al. December 2, 2
2014-12-02
Tryptophanyl-tRNA synthetase-derived polypeptides useful for the regulation of angiogenesis
Grant 8,796,237 - Schimmel , et al. August 5, 2
2014-08-05
TRYPTOPHANYL-tRNA SYNTHETASE-DERIVED POLYPEPTIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS
App 20120238620 - Schimmel; Paul ;   et al.
2012-09-20
Selective R-cadherin antagonists and methods
Grant 8,163,697 - Friedlander , et al. April 24, 2
2012-04-24
Isolated monocyte populations and related therapeutic applications
App 20120009166 - Friedlander; Martin ;   et al.
2012-01-12
Tryptophanyl-tRNA synthetase-derived polypeptides useful for the regulation of angiogenesis
Grant 8,017,593 - Schimmel , et al. September 13, 2
2011-09-13
Isolated Myeloid-like Bone Marrow Cell Populations And Methods Of Treatment Therewith
App 20110201108 - FRIEDLANDER; Martin ;   et al.
2011-08-18
Hematopoietic Stem Cells And Methods Of Treatment Of Neovascular Eye Diseases Therewith
App 20110104131 - FRIEDLANDER; Martin ;   et al.
2011-05-05
Isolated myeloid-like bone marrow cell populations and methods of treatment therewith
Grant 7,931,891 - Friedlander , et al. April 26, 2
2011-04-26
Isolated lineage negative hematopoietic stem cells and methods of treatment therewith
App 20100303768 - Friedlander; Martin ;   et al.
2010-12-02
Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith
Grant 7,838,290 - Friedlander , et al. November 23, 2
2010-11-23
Isolated myeloid-like cell populations and methods of treatment therewith
App 20100254952 - Friedlander; Martin ;   et al.
2010-10-07
Methods and compositions for the treatment of diseases of the eye
Grant 7,648,959 - Bender , et al. January 19, 2
2010-01-19
Integrin inhibitors for the treatment of eye diseases
Grant 7,645,736 - Bender , et al. January 12, 2
2010-01-12
Compositions and methods for treatment of neovascular diseases
App 20090285792 - Friedlander; Martin ;   et al.
2009-11-19
Tryptophanyl-tRNA synthetase-derived polypeptides useful for the regulation of angiogenesis
App 20090275643 - Schimmel; Paul ;   et al.
2009-11-05
Selective R-cadherin antagonists and methods
App 20090124538 - Friedlander; Martin ;   et al.
2009-05-14
Compositions and methods for treatment of neovascular diseases
Grant 7,528,106 - Friedlander , et al. May 5, 2
2009-05-05
Tryptophanyl-tRNA synthetase-derived polypeptides useful for the regulation of angiogenesis
Grant 7,476,651 - Schimmel , et al. January 13, 2
2009-01-13
Method for the Treatment of Retinopathy of Prematurity and Related Retinopathic Diseases
App 20080317721 - Friedlander; Martin ;   et al.
2008-12-25
Selective R-cadherin antagonist and methods
Grant 7,419,953 - Friedlander , et al. September 2, 2
2008-09-02
Tryptophanyl-tRNA synthetase-derived polypeptides useful for the regulation of angiogenesis
Grant 7,413,885 - Schimmel , et al. August 19, 2
2008-08-19
Isolated Myeloid-Like Bone Marrow Cell Populations and Methods of Treatment Therewith
App 20080194018 - Friedlander; Martin ;   et al.
2008-08-14
Revascularization of Ischemic Retinal Tissue and Screening Method Therefor
App 20080193435 - Friedlander; Martin ;   et al.
2008-08-14
Tryptophanyl-tRNA synthetase-derived polypeptides useful for the regulation of angiogenesis
App 20080064639 - Schimmel; Paul ;   et al.
2008-03-13
Treatment of cone cell degeneration with transfected lineage negative hematopoietic stem cells
App 20070231310 - Friedlander; Martin ;   et al.
2007-10-04
Isolated myeloid-like cell populations and methods of treatment therewith
App 20070231306 - Friedlander; Martin ;   et al.
2007-10-04
Tryptophanyl-tRNA synthetase-derived polypeptides useful for the regulation of angiogenesis
Grant 7,273,844 - Schimmel , et al. September 25, 2
2007-09-25
Tryptophanyl-tRNA synthetase-derived polypeptides useful for the regulation of angiogenesis
App 20070218527 - Schimmel; Paul ;   et al.
2007-09-20
Method Of Modulating Vascularization
App 20070207154 - Friedlander; Martin ;   et al.
2007-09-06
Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith
App 20070116685 - Friedlander; Martin ;   et al.
2007-05-24
Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith
Grant 7,153,501 - Friedlander , et al. December 26, 2
2006-12-26
Integrin inhibitors for the treatment of eye diseases
App 20060287225 - Bender; Hans-Markus ;   et al.
2006-12-21
Methods and compositions for the treatment of diseases of the eye
App 20060223746 - Bender; Hans-Markus ;   et al.
2006-10-05
Methods and compositions useful for inhibition of alpha v beta 5 mediated angiogenesis
App 20060165703 - Brooks; Peter ;   et al.
2006-07-27
Methods and compositions useful for inhibition of .alpha..sub.v.beta..sub.5mediated angiogenesis
Grant 7,053,041 - Brooks , et al. May 30, 2
2006-05-30
Transfected hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith
App 20060104962 - Friedlander; Martin ;   et al.
2006-05-18
Treatment of cone cell degeneration with transfected lineage negative hematopoietic stem cells
App 20060104963 - Friedlander; Martin ;   et al.
2006-05-18
Compositions and methods for treatment of neovascular diseases
App 20060003933 - Friedlander; Martin ;   et al.
2006-01-05
Tryptophanyl-tRNA synthetase-derived polypeptides useful for the regulation of angiogenesis
App 20050197298 - Schimmel, Paul ;   et al.
2005-09-08
Isolated lineage negative hematopoietic stem cells and methods of treatment therewith
App 20050129665 - Friedlander, Martin ;   et al.
2005-06-16
Methods and compositions for the treatment of eye diseases
App 20050085415 - Wiesner, Matthias ;   et al.
2005-04-21
Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith
App 20050063961 - Friedlander, Martin ;   et al.
2005-03-24
Selective R-cadherin antagonist and methods
App 20050004013 - Friedlander, Martin ;   et al.
2005-01-06
Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith
App 20040197902 - Friedlander, Martin ;   et al.
2004-10-07
Integrin inhibitors for the treatment of eye diseases
App 20040198644 - Bender, Hans-Markus ;   et al.
2004-10-07
Methods and compositions for the treatment of diseases of the eye
App 20040029788 - Bender, Hans-Markus ;   et al.
2004-02-12
Tryptophanyl-tRNA synthetase derived polypeptides useful for the regulation of angiogenesis
App 20030017564 - Schimmel, Paul ;   et al.
2003-01-23
Vectors for occular transduction and use therefor for genetic therapy
App 20020193327 - Nemerow, Glen R. ;   et al.
2002-12-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed